The UK sets a record 22.9% payment rate under the 2025 VPAG for branded medicines, sparking criticism from the pharma industry. The ABPI warns the increase threatens industry growth and the UK’s ...
Moderna and Novo Nordisk are once again in the bad books of the U.K.’s drug marketing watchdog. | Moderna and Novo Nordisk ...
Novo Nordisk (NVO) has reportedly been criticized by the U.K.'s Prescription Medicines Code of Practice Authority, or PMCPA, for mischaracterizing certain payments to patients and healthcare groups.
The Association of the British Pharmaceutical Industry (ABPI) has added five new patient organisation figures to its patient advisory council, set up to provide patient perspective on its policy ...
Sarah has chaired the Healthy Air Coalition, a collective of leading health and environmental charities campaigning for cleaner air, is a previous co-chair of the National Respiratory Delivery Board, ...
The analysis, published by the Association of the British Pharmaceutical Industry (ABPI), is an encouraging sign but “is not yet enough to restore the UK’s global ranking on trials ...